General Session

EPIC-SEC 2017

Interventional Cardiology and Cardiac Surgery: Current Status and Future Directions

Thursday, April 20
7:35 AM - 9:00 AM

Habib Samady

Professor of Medicine
Emory University School of Medicine
Emory University School of Medicine

Dr. Samady trained in general cardiology, nuclear cardiology and interventional cardiology at Yale University School of Medicine from 1994 to 1999. He was Assistant Professor of Medicine at University of Virginia from 1999-2003 and Clinical Associate Professor of Medicine at Eastern Virginia Medical School from 2003-2005. He joined the Division of Cardiology at Emory University in 2005. In 2009, he became Professor of Medicine and in 2011, Director of Interventional Cardiology at Emory University and Director of the Cardiac Catheterization Laboratory of EUH. He has supervised and participated in the training of over 60 interventional cardiology fellows and over 100 general cardiology fellows.

Send Email for Habib Samady

Manesh R. Patel

Director Interventional Cardiology and Catheterization Labs
Duke University Medical Center

Dr. Patel is cardiology section leader in Interventional Cardiology and Director of Cardiac Cath Labs for the Duke University Health System. His interests included peripheral and percutaneous intervention, and he is involved in several trials involving patients with vascular disease. He is also a member of the American College of Cardiology Task Force for Appropriate use of Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee.

Send Email for Manesh Patel

Steven F. Bolling

University of Michigan Health Systems
University of Michigan Frankel Cardiovascular Center

Dr. Steven F. Bolling is a Professor of Surgery in the Department of Cardiac Surgery at the University of Michigan. Both his undergraduate and medical school education were at the University of Michigan. Following this, he trained in general and thoracic surgery at Johns Hopkins.

He joined the Cardiac Surgery faculty at the University of Michigan in the mid-1980s and helped create and direct the multi-disciplinary mitral valve clinic. He is an active participant in all the major cardiac surgical societies and a recognized expert in mitral valve surgery. He is the author of over 350 peer-reviewed publications and holds numerous grants, including NIH, AHA, and industry grants.

He is the Director of the Myocellular Biology Laboratory. His research is in the molecular biology of heart failure, with a special interest in myocyte signal transduction. He is also the Director of the Multidisciplinary Mitral Valve Clinic.

Send Email for Steven Bolling

Martin B. Leon

Director, Center for Interventional Vascular Therapy
Columbia University Medical Center
Cardiovascular Research Foundation

Martin B. Leon, MD, is a Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy (CIVT) at NewYork-Presbyterian Hospital/Columbia University Medical Center. Previously, Dr. Leon was also the Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center and currently he serves on the Executive Board of the NewYork-Presbyterian/Columbia Heart Valve Center. Dr. Leon was the Founder and Chairman Emeritus of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director, Medical Research and Education Division. CRF is the largest independent not-for-profit cardiovascular research center in the United States.
A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national principal investigator for over 50 clinical trials that have helped shape the field including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis.


Send Email for Martin Leon

Ron Waksman

Director, Cardiovascular Research and Advanced Education
MedStar Heart and Vascular Institute
Georgetown University

Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.

He earned his medical degree from the Ben Gurion University in Israel and completed residencies in medicine, cardiology, and interventional cardiology at Hadassah University in Jerusalem, Israel. Subsequently, Dr. Waksman completed his fellowship in interventional cardiology in 1994 at Emory University Hospital in Atlanta, GA.

Send Email for Ron Waksman

Stephan Windecker

Professor and Chairman
Department of Cardiology, Bern University Hospital
Bern University

Since 2015, Prof. Windecker has been the Chairman and Director of the Department of Cardiology at the Swiss Cardiovascular Center Bern, Switzerland. He is an interventional cardiologist by training and has previously served as Director of Invasive Cardiology at Bern University Hospital from 2002 to 2015. He is full Professor of Cardiology at the University of Bern, Switzerland and executive board member of the Clinical Trials Unit at Bern University Hospital. Prof. Windecker is currently Chairman of the Clinical Practice Guidelines Committee of the European Society of Cardiology . He is also one of the course directors of EuroPCR and PCR London Valves. Prof. Windecker has been a Fulbright scholar and received the I2-summit Innovator 2005 Award of the American College of Cardiology.
Prof. Windecker’s main research interests focus on the evaluation of intracoronary devices for the treatment of coronary artery disease, research related to structural heart disease including transcatheter aortic, mitral, and tricuspid valve interventions, patent foramen ovale (PFO), left atrial appendage occlusion as well as percutaneous left ventricular assist devices.

Send Email for Stephan Windecker

Spencer B. King

Professor of Medicine Emeritus
Emory University School of Medicine
Emory University School of Medicine

Dr. King is Professor of Medicine Emeritus of Emory University School of Medicine & Editor-in-Chief, JACC: Cardiovascular Interventions. A pioneer in interventional cardiology, he trained 150+ invasive/interventional cardiology fellows & conducted the 1st NHLBI trial of coronary angioplasty vs bypass surgery. He served as President, American College of Cardiology (1998-1999), and has authored 500+ papers & edited/co-edited 10 books including Interventional Cardiology and Hurst’s The Heart 9th-13th Eds.

Send Email for Spencer King

Roxana Mehran

Professor of Medicine (Cardiology) and Population Health Science and Policy
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai

Roxana Mehran, MD, FACC is a physician and an internationally renowned influencer in the field of interventional cardiovascular disease. Throughout her career as an academician, clinician, and researcher she has achieved the highest levels of recognition for her knowledge, expertise, and accomplishments within the field.
Currently a Professor of Medicine, Cardiology, Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York; also Director of Interventional Cardiovascular Research and Clinical Trials at Mount Sinai Hospita.Over the past five years, she has led the development of a globally-respected data and clinical coordination center to support large, multicenter, multinational clinical trials designed, by her team, to help clinicians improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. Her work has had a special emphasis on gaining a deeper understanding of anticoagulation, antiplatelet regimens post angioplasty and transcatheter valve replacement; and collection and interpretation of sex-specific data in cardiovascular clinical trials.

Send Email for Roxana Mehran


Assets

Interventional Cardiology and Cardiac Surgery: Current Status and Future Directions



Attendees who have favorited this

Send Email for Interventional Cardiology and Cardiac Surgery: Current Status and Future Directions